Exact Mass: 618.4859

Exact Mass Matches: 618.4859

Found 500 metabolites which its exact mass value is equals to given mass value 618.4859, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

DG(15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/15:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propan-2-yl pentadecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/15:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/15:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl pentadecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/15:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/15:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl pentadecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,11Z,14Z)-O(8,9)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/15:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/15:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl pentadecanoic acid

C38H66O6 (618.4859)


DG(20:3(8Z,11Z,14Z)-O(5,6)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/15:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl pentadecanoic acid

C38H66O6 (618.4859)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C38H66O6 (618.4859)


DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5R,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-15:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propan-2-yl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-15:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-15:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-15:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/a-15:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,11Z,14Z)-O(8,9)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-15:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/a-15:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(8Z,11Z,14Z)-O(5,6)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 12-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5R,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-15:0/0:0)

(2S)-3-hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-15:0)

(2S)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(a-15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-15:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propan-2-yl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-15:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxy}propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-15:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-15:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-15:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,11Z,14Z)-O(8,9)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-15:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-15:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(8Z,11Z,14Z)-O(5,6)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 13-methyltetradecanoic acid

C38H66O6 (618.4859)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5R,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-15:0/0:0)

(2S)-3-hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-15:0)

(2S)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C38H66O6 (618.4859)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(i-15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C38H66O6 (618.4859)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

1-[3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy]-25,27-dihydroxyoctacosane-3-one

1-[3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy]-25,27-dihydroxyoctacosane-3-one

C34H66O9 (618.4707)


   

Cycloartenyl ferulate

Cycloartenyl ferulate

C41H62O4 (618.4648)


   

beta-sitosteryl ferulate

beta-sitosteryl ferulate

C41H62O4 (618.4648)


   

calcaratarin E

calcaratarin E

C41H62O4 (618.4648)


   

1-(O-alpha-D-glucopyranosyl)-3-keto-(1,25R,27R)-octacosanetriol

1-(O-alpha-D-glucopyranosyl)-3-keto-(1,25R,27R)-octacosanetriol

C34H66O9 (618.4707)


   

1-(O-alpha-D-glucopyranosyl)-25-keto-(1,3R,27R)-octacosanetriol

1-(O-alpha-D-glucopyranosyl)-25-keto-(1,3R,27R)-octacosanetriol

C34H66O9 (618.4707)


   

1-(O-alpha-D-mannopyranosyl)-25-keto-(1,3R,27R)-octacosanetriol

1-(O-alpha-D-mannopyranosyl)-25-keto-(1,3R,27R)-octacosanetriol

C34H66O9 (618.4707)


   

Nonaflavuxanthin

2-(4-Hydroxy-3-methylbut-2-enyl)-1,3,4,16-tetradehydro-1,2-dihydro-psi,psi-carotene

C45H62O (618.48)


   

MAGNESIUM RICINOLEATE

MAGNESIUM RICINOLEATE

C36H66MgO6 (618.471)


   

Kojic acid dipalmitate

Kojic acid dipalmitate

C38H66O6 (618.4859)


   

DG(15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/15:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/15:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/15:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/15:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/15:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C38H66O6 (618.4859)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/15:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/15:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C38H66O6 (618.4859)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/15:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/15:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C38H66O6 (618.4859)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/15:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/15:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/15:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/15:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/15:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/15:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C38H66O6 (618.4859)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/15:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/15:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/15:0/0:0)

C38H66O6 (618.4859)


   

DG(15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C38H66O6 (618.4859)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/15:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(a-15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-15:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(a-15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-15:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(a-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-15:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(a-15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-15:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(a-15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/a-15:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(a-15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C38H66O6 (618.4859)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-15:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(a-15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/a-15:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(a-15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C38H66O6 (618.4859)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-15:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(a-15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-15:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C38H66O6 (618.4859)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-15:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(a-15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(a-15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-15:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-15:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(a-15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-15:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(a-15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-15:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(a-15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-15:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(a-15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C38H66O6 (618.4859)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-15:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(a-15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(a-15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-15:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-15:0/0:0)

C38H66O6 (618.4859)


   

DG(a-15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(a-15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C38H66O6 (618.4859)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-15:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(i-15:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-15:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(i-15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-15:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(i-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-15:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(i-15:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C38H66O6 (618.4859)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-15:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(i-15:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-15:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(i-15:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C38H66O6 (618.4859)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-15:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(i-15:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C38H66O6 (618.4859)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-15:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(i-15:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C38H66O6 (618.4859)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-15:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(i-15:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-15:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C38H66O6 (618.4859)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-15:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(i-15:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-15:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-15:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(i-15:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-15:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-15:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(i-15:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-15:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(i-15:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C38H66O6 (618.4859)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-15:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(i-15:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-15:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(i-15:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C38H66O6 (618.4859)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-15:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-15:0)

C38H66O6 (618.4859)


   

DG(i-15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(i-15:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C38H66O6 (618.4859)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-15:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-15:0/0:0)

C38H66O6 (618.4859)


   

DG(i-15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(i-15:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C38H66O6 (618.4859)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-15:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-15:0)

C38H66O6 (618.4859)


   

CID 91820177

CID 91820177

C45H62O (618.48)


   

NAOrn 16:1/16:2

NAOrn 16:1/16:2

C37H66N2O5 (618.4971)


   

NAOrn 14:0/18:3

NAOrn 14:0/18:3

C37H66N2O5 (618.4971)


   

NAOrn 13:1/19:2

NAOrn 13:1/19:2

C37H66N2O5 (618.4971)


   

NAOrn 17:2/15:1

NAOrn 17:2/15:1

C37H66N2O5 (618.4971)


   

NAOrn 20:3/12:0

NAOrn 20:3/12:0

C37H66N2O5 (618.4971)


   

NAOrn 18:3/14:0

NAOrn 18:3/14:0

C37H66N2O5 (618.4971)


   

NAOrn 19:2/13:1

NAOrn 19:2/13:1

C37H66N2O5 (618.4971)


   

NAOrn 15:1/17:2

NAOrn 15:1/17:2

C37H66N2O5 (618.4971)


   

NAOrn 10:0/22:3

NAOrn 10:0/22:3

C37H66N2O5 (618.4971)


   

NAOrn 16:0/16:3

NAOrn 16:0/16:3

C37H66N2O5 (618.4971)


   

NAOrn 14:1/18:2

NAOrn 14:1/18:2

C37H66N2O5 (618.4971)


   

NAOrn 12:0/20:3

NAOrn 12:0/20:3

C37H66N2O5 (618.4971)


   

NAOrn 16:3/16:0

NAOrn 16:3/16:0

C37H66N2O5 (618.4971)


   

NAOrn 18:2/14:1

NAOrn 18:2/14:1

C37H66N2O5 (618.4971)


   

NAOrn 22:3/10:0

NAOrn 22:3/10:0

C37H66N2O5 (618.4971)


   

NAOrn 16:2/16:1

NAOrn 16:2/16:1

C37H66N2O5 (618.4971)


   

Mgdg O-22:0_3:0

Mgdg O-22:0_3:0

C34H66O9 (618.4707)


   

Mgdg O-8:0_17:0

Mgdg O-8:0_17:0

C34H66O9 (618.4707)


   

Mgdg O-18:0_7:0

Mgdg O-18:0_7:0

C34H66O9 (618.4707)


   

Mgdg O-17:0_8:0

Mgdg O-17:0_8:0

C34H66O9 (618.4707)


   

Mgdg O-19:0_6:0

Mgdg O-19:0_6:0

C34H66O9 (618.4707)


   

Mgdg O-23:0_2:0

Mgdg O-23:0_2:0

C34H66O9 (618.4707)


   

Mgdg O-21:0_4:0

Mgdg O-21:0_4:0

C34H66O9 (618.4707)


   

Mgdg O-16:0_9:0

Mgdg O-16:0_9:0

C34H66O9 (618.4707)


   

Mgdg O-20:0_5:0

Mgdg O-20:0_5:0

C34H66O9 (618.4707)


   

Mgdg O-9:0_16:0

Mgdg O-9:0_16:0

C34H66O9 (618.4707)


   

Mgdg O-11:0_14:0

Mgdg O-11:0_14:0

C34H66O9 (618.4707)


   

Mgdg O-13:0_12:0

Mgdg O-13:0_12:0

C34H66O9 (618.4707)


   

Mgdg O-14:0_11:0

Mgdg O-14:0_11:0

C34H66O9 (618.4707)


   

Mgdg O-15:0_10:0

Mgdg O-15:0_10:0

C34H66O9 (618.4707)


   

Mgdg O-10:0_15:0

Mgdg O-10:0_15:0

C34H66O9 (618.4707)


   

Mgdg O-12:0_13:0

Mgdg O-12:0_13:0

C34H66O9 (618.4707)


   

PE-Cer 16:1;2O/15:0

PE-Cer 16:1;2O/15:0

C33H67N2O6P (618.4736)


   

PE-Cer 19:1;2O/12:0

PE-Cer 19:1;2O/12:0

C33H67N2O6P (618.4736)


   

PE-Cer 13:1;2O/18:0

PE-Cer 13:1;2O/18:0

C33H67N2O6P (618.4736)


   

PE-Cer 12:1;2O/19:0

PE-Cer 12:1;2O/19:0

C33H67N2O6P (618.4736)


   

PE-Cer 15:0;2O/16:1

PE-Cer 15:0;2O/16:1

C33H67N2O6P (618.4736)


   

PE-Cer 18:1;2O/13:0

PE-Cer 18:1;2O/13:0

C33H67N2O6P (618.4736)


   

PE-Cer 15:1;2O/16:0

PE-Cer 15:1;2O/16:0

C33H67N2O6P (618.4736)


   

PE-Cer 17:0;2O/14:1

PE-Cer 17:0;2O/14:1

C33H67N2O6P (618.4736)


   

PE-Cer 14:1;2O/17:0

PE-Cer 14:1;2O/17:0

C33H67N2O6P (618.4736)


   

PE-Cer 12:0;2O/19:1

PE-Cer 12:0;2O/19:1

C33H67N2O6P (618.4736)


   

PE-Cer 13:0;2O/18:1

PE-Cer 13:0;2O/18:1

C33H67N2O6P (618.4736)


   

PE-Cer 16:0;2O/15:1

PE-Cer 16:0;2O/15:1

C33H67N2O6P (618.4736)


   

PE-Cer 18:0;2O/13:1

PE-Cer 18:0;2O/13:1

C33H67N2O6P (618.4736)


   

PE-Cer 14:0;2O/17:1

PE-Cer 14:0;2O/17:1

C33H67N2O6P (618.4736)


   

PE-Cer 17:1;2O/14:0

PE-Cer 17:1;2O/14:0

C33H67N2O6P (618.4736)


   

[(E)-3-hydroxy-2-(nonadecanoylamino)non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(nonadecanoylamino)non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-3-hydroxy-2-(pentanoylamino)tricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentanoylamino)tricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-3-hydroxy-2-(nonanoylamino)nonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(nonanoylamino)nonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-3-hydroxy-2-(octanoylamino)icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(octanoylamino)icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-3-hydroxy-2-(icosanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(icosanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-2-(hexanoylamino)-3-hydroxydocos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexanoylamino)-3-hydroxydocos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-2-(heptanoylamino)-3-hydroxyhenicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptanoylamino)-3-hydroxyhenicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-2-(butanoylamino)-3-hydroxytetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(butanoylamino)-3-hydroxytetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-2-acetamido-3-hydroxyhexacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-acetamido-3-hydroxyhexacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C41H62O4 (618.4648)


   

[(E)-3-hydroxy-2-(propanoylamino)pentacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(propanoylamino)pentacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C41H62O4 (618.4648)


   

[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C41H62O4 (618.4648)


   

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C41H62O4 (618.4648)


   

[(E)-3-hydroxy-2-(octadecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(octadecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-2-(heptadecanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptadecanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-2-(hexadecanoylamino)-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexadecanoylamino)-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-3-hydroxy-2-(undecanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(undecanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-3-hydroxy-2-(pentadecanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentadecanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-2-(decanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(decanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

(2-nonanoyloxy-3-octanoyloxypropyl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

(2-nonanoyloxy-3-octanoyloxypropyl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C38H66O6 (618.4859)


   

(2-decanoyloxy-3-nonanoyloxypropyl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

(2-decanoyloxy-3-nonanoyloxypropyl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C38H66O6 (618.4859)


   

(3-octanoyloxy-2-undecanoyloxypropyl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

(3-octanoyloxy-2-undecanoyloxypropyl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C38H66O6 (618.4859)


   

[3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-3-hydroxy-2-(tetradecanoylamino)tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tetradecanoylamino)tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-3-hydroxy-2-(tridecanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tridecanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E)-2-(dodecanoylamino)-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(dodecanoylamino)-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

N-(tetradecanoyl)-4E-tetradecasphingenine-1-phosphocholine

N-(tetradecanoyl)-4E-tetradecasphingenine-1-phosphocholine

C33H67N2O6P (618.4736)


   

N-(decanoyl)-4E-sphingenine-1-phosphocholine

N-(decanoyl)-4E-sphingenine-1-phosphocholine

C33H67N2O6P (618.4736)


   

N-(tridecanoyl)-4E-pentadecasphingenine-1-phosphocholine

N-(tridecanoyl)-4E-pentadecasphingenine-1-phosphocholine

C33H67N2O6P (618.4736)


   

N-(dodecanoyl)-4E-hexadecasphingenine-1-phosphocholine

N-(dodecanoyl)-4E-hexadecasphingenine-1-phosphocholine

C33H67N2O6P (618.4736)


   

[(E,2S,3R)-2-(dodecanoylamino)-3-hydroxyhexadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-2-(dodecanoylamino)-3-hydroxyhexadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E,2S,3R)-3-hydroxy-2-(tridecanoylamino)pentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-3-hydroxy-2-(tridecanoylamino)pentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E,2S,3R)-2-(decanoylamino)-3-hydroxyoctadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-2-(decanoylamino)-3-hydroxyoctadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

[(E,2S,3R)-3-hydroxy-2-(tetradecanoylamino)tetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-3-hydroxy-2-(tetradecanoylamino)tetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H67N2O6P (618.4736)


   

2-[[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO6P+ (618.4862)


   

SM(28:1)

SM(d16:1_12:0)

C33H67N2O6P (618.4736)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(35:3)

TG(15:0_10:1_10:2)

C38H66O6 (618.4859)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

FAHFA 15:2/O-26:7

FAHFA 15:2/O-26:7

C41H62O4 (618.4648)


   

FAHFA 15:3/O-26:6

FAHFA 15:3/O-26:6

C41H62O4 (618.4648)


   

FAHFA 15:4/O-26:5

FAHFA 15:4/O-26:5

C41H62O4 (618.4648)


   

FAHFA 15:5/O-26:4

FAHFA 15:5/O-26:4

C41H62O4 (618.4648)


   

FAHFA 16:2/O-25:7

FAHFA 16:2/O-25:7

C41H62O4 (618.4648)


   

FAHFA 16:3/O-25:6

FAHFA 16:3/O-25:6

C41H62O4 (618.4648)


   

FAHFA 16:4/O-25:5

FAHFA 16:4/O-25:5

C41H62O4 (618.4648)


   

FAHFA 16:5/O-25:4

FAHFA 16:5/O-25:4

C41H62O4 (618.4648)


   

FAHFA 17:2/O-24:7

FAHFA 17:2/O-24:7

C41H62O4 (618.4648)


   

FAHFA 17:3/O-24:6

FAHFA 17:3/O-24:6

C41H62O4 (618.4648)


   

FAHFA 17:4/O-24:5

FAHFA 17:4/O-24:5

C41H62O4 (618.4648)


   

FAHFA 17:5/O-24:4

FAHFA 17:5/O-24:4

C41H62O4 (618.4648)


   

FAHFA 18:2/O-23:7

FAHFA 18:2/O-23:7

C41H62O4 (618.4648)


   

FAHFA 18:3/O-23:6

FAHFA 18:3/O-23:6

C41H62O4 (618.4648)


   

FAHFA 18:4/O-23:5

FAHFA 18:4/O-23:5

C41H62O4 (618.4648)


   

FAHFA 18:5/O-23:4

FAHFA 18:5/O-23:4

C41H62O4 (618.4648)


   

FAHFA 18:6/O-23:3

FAHFA 18:6/O-23:3

C41H62O4 (618.4648)


   

FAHFA 19:2/O-22:7

FAHFA 19:2/O-22:7

C41H62O4 (618.4648)


   

FAHFA 19:3/O-22:6

FAHFA 19:3/O-22:6

C41H62O4 (618.4648)


   

FAHFA 19:4/O-22:5

FAHFA 19:4/O-22:5

C41H62O4 (618.4648)


   

FAHFA 19:5/O-22:4

FAHFA 19:5/O-22:4

C41H62O4 (618.4648)


   

FAHFA 19:6/O-22:3

FAHFA 19:6/O-22:3

C41H62O4 (618.4648)


   

FAHFA 20:2/O-21:7

FAHFA 20:2/O-21:7

C41H62O4 (618.4648)


   

FAHFA 20:3/O-21:6

FAHFA 20:3/O-21:6

C41H62O4 (618.4648)


   

FAHFA 20:4/O-21:5

FAHFA 20:4/O-21:5

C41H62O4 (618.4648)


   

FAHFA 20:5/O-21:4

FAHFA 20:5/O-21:4

C41H62O4 (618.4648)


   

FAHFA 20:6/O-21:3

FAHFA 20:6/O-21:3

C41H62O4 (618.4648)


   

FAHFA 21:3/O-20:6

FAHFA 21:3/O-20:6

C41H62O4 (618.4648)


   

FAHFA 21:4/O-20:5

FAHFA 21:4/O-20:5

C41H62O4 (618.4648)


   

FAHFA 21:5/O-20:4

FAHFA 21:5/O-20:4

C41H62O4 (618.4648)


   

MGDG O-25:0

MGDG O-25:0

C34H66O9 (618.4707)


   
   

CerPE 14:0;O2/17:1

CerPE 14:0;O2/17:1

C33H67N2O6P (618.4736)


   

CerPE 14:1;O2/17:0

CerPE 14:1;O2/17:0

C33H67N2O6P (618.4736)


   

CerPE 15:0;O2/16:1

CerPE 15:0;O2/16:1

C33H67N2O6P (618.4736)


   

CerPE 15:1;O2/16:0

CerPE 15:1;O2/16:0

C33H67N2O6P (618.4736)


   

CerPE 16:0;O2/15:1

CerPE 16:0;O2/15:1

C33H67N2O6P (618.4736)


   

CerPE 16:1;O2/15:0

CerPE 16:1;O2/15:0

C33H67N2O6P (618.4736)


   

CerPE 17:0;O2/14:1

CerPE 17:0;O2/14:1

C33H67N2O6P (618.4736)


   

CerPE 17:1;O2/14:0

CerPE 17:1;O2/14:0

C33H67N2O6P (618.4736)


   

CerPE 18:1;O2/13:0

CerPE 18:1;O2/13:0

C33H67N2O6P (618.4736)


   

CerPE 19:1;O2/12:0

CerPE 19:1;O2/12:0

C33H67N2O6P (618.4736)


   

CerPE 20:1;O2/11:0

CerPE 20:1;O2/11:0

C33H67N2O6P (618.4736)


   

CerPE 21:1;O2/10:0

CerPE 21:1;O2/10:0

C33H67N2O6P (618.4736)


   
   
   
   
   
   
   
   
   
   

25,27-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-3-one

25,27-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-3-one

C34H66O9 (618.4707)


   

(25s,27r)-25,27-dihydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-3-one

(25s,27r)-25,27-dihydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-3-one

C34H66O9 (618.4707)


   

2-hydroxy-3-{[(2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-yl]oxy}propyl pentacosanoate

2-hydroxy-3-{[(2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-yl]oxy}propyl pentacosanoate

C38H66O6 (618.4859)